These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening, identification, and characterization of mechanistically diverse inhibitors of the Mycobacterium tuberculosis enzyme, pantothenate kinase (CoaA). Venkatraman J, Bhat J, Solapure SM, Sandesh J, Sarkar D, Aishwarya S, Mukherjee K, Datta S, Malolanarasimhan K, Bandodkar B, Das KS. J Biomol Screen; 2012 Mar; 17(3):293-302. PubMed ID: 22086722 [Abstract] [Full Text] [Related]
3. Calculating the probability of detection for inhibitors in enzymatic or binding reactions in high-throughput screening. Buxser S, Vroegop S. Anal Biochem; 2005 May 01; 340(1):1-13. PubMed ID: 15802124 [Abstract] [Full Text] [Related]
4. Defining balanced conditions for inhibitor screening assays that target bisubstrate enzymes. Yang J, Copeland RA, Lai Z. J Biomol Screen; 2009 Feb 01; 14(2):111-20. PubMed ID: 19196704 [Abstract] [Full Text] [Related]
5. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin. Jenkins JL, Kao RY, Shapiro R. Proteins; 2003 Jan 01; 50(1):81-93. PubMed ID: 12471601 [Abstract] [Full Text] [Related]
6. Analysis of a high-throughput screening data set using potency-scaled molecular similarity algorithms. Vogt I, Bajorath J. J Chem Inf Model; 2007 Jan 01; 47(2):367-75. PubMed ID: 17300172 [Abstract] [Full Text] [Related]
7. Scoring ligand similarity in structure-based virtual screening. Zavodszky MI, Rohatgi A, Van Voorst JR, Yan H, Kuhn LA. J Mol Recognit; 2009 Jan 01; 22(4):280-92. PubMed ID: 19235177 [Abstract] [Full Text] [Related]
13. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening. Zhang JH, Roddy TP, Ho PI, Horvath CR, Vickers C, Stout S, Hubbard B, Wang YK, Hill WA, Bojanic D. J Biomol Screen; 2010 Jul 01; 15(6):695-702. PubMed ID: 20484097 [Abstract] [Full Text] [Related]
14. Nonmevalonate terpene biosynthesis enzymes as antiinfective drug targets: substrate synthesis and high-throughput screening methods. Illarionova V, Kaiser J, Ostrozhenkova E, Bacher A, Fischer M, Eisenreich W, Rohdich F. J Org Chem; 2006 Nov 10; 71(23):8824-34. PubMed ID: 17081012 [Abstract] [Full Text] [Related]
15. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Lo MC, Aulabaugh A, Jin G, Cowling R, Bard J, Malamas M, Ellestad G. Anal Biochem; 2004 Sep 01; 332(1):153-9. PubMed ID: 15301960 [Abstract] [Full Text] [Related]
16. Identification of selective enzyme inhibitors by fragment library screening. Gao G, Liu X, Pavlovsky A, Viola RE. J Biomol Screen; 2010 Oct 01; 15(9):1042-50. PubMed ID: 20855558 [Abstract] [Full Text] [Related]
17. Selection of in silico drug screening results by using universal active probes (UAPs). Fukunishi Y, Ohno K, Orita M, Nakamura H. J Chem Inf Model; 2010 Jul 26; 50(7):1233-40. PubMed ID: 20578712 [Abstract] [Full Text] [Related]
18. Identification of iNOS inhibitors using InteraX. Mallinder PR, Wallace AV, Allenby G. J Biomol Screen; 2009 Mar 26; 14(3):263-72. PubMed ID: 19211775 [Abstract] [Full Text] [Related]